Clinical trial
Endogenous Heat-shock Vaccines for Melanoma A Feasibility Study
NCT00568763 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endogenous Heat-shock Vaccines for Melanoma A Feasibility Study
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 25, 2005
- Completion date
- May 24, 2018
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma (skin)